PubMed · 1999 · 30 citations · 0 references
MedicineDermatologyPathologyCutaneous OncologyDermatopathologyImmunopathologyCutaneous LymphomaCutaneous NeoplasmsImmunopathology Of SkinInflammatory DermatosesInflammatory Skin DisordersSkin TumorsBenign Skin NeoplasmsCutaneous Immune-mediated DiseaseCutaneous ImmunologyCutaneous T-cell Lymphoma ImmunopathologyCutaneous T-cell Lymphoma TreatmentT Helper CellsT-cell Mediated Skin Disease
Cutaneous T-cell lymphoma, also known as mycosis fungoides, is a malignancy of the T helper (CD4+) cells. Diagnosis is difficult early in the course of this disease because it mimics several benign skin disorders, including eczema, psoriasis and contact dermatitis. Cutaneous T-cell lymphoma is also difficult to identify histologically, and multiple biopsies may be necessary to confirm the diagnosis. Treatment may require a combination of topical and systemic agents. Patients with limited skin disease have a good prognosis, but the prognosis is less hopeful in those with extracutaneous involvement. As the disease progresses, the normal T-cell population is eliminated, and the patient becomes significantly immunosuppressed. Infection is the primary cause of mortality in patients with cutaneous T-cell lymphoma.